1-2 of 2
Crispin Semakula
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis: A randomized controlled trial

Guillermo E. Umpierrez, MD, Sidney Jones, MD, Dawn Smiley, MD, Patrick Mulligan, BA, Trevor Keyler, Angel Temponi, MD, Crispin Semakula, MD, Denise Umpierrez, BA, Limin Peng, PHD, Miguel Cerón, MD, Gonzalo Robalino, MD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1164–1169
https://doi.org/10.2337/dc09-0169
Published: 14 April 2009
View article titled, Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis: <subtitle>A randomized controlled trial</subtitle>
Open the PDF for Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis: <subtitle>A randomized controlled trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry

Christina L Vandewalle, MD, Alberto Falorni, MD, PHD, Åke Lernmark, MD, PHD, Patrick Goubert, Harry Dorchy, MD, PHD, Willy Coucke, MD, Crispin Semakula, MD, Bart Van Der Auwera, MD, Leon Kaufman, MSC, PHD, Frans C Schuit, MD, PHD, Daniël G Pipeleers, MD, PHD, Frans K Gorus, MD, PHD
Journal: Diabetes Care
Diabetes Care 1997;20(10):1547–1552
https://doi.org/10.2337/diacare.20.10.1547
Published: 01 October 1997
View article titled, Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry
Open the PDF for Associations of GAD65- and IA-2-Autoantibodies With Genetic Risk Markers in New-Onset IDDM Patients and Their Siblings. The Belgian Diabetes Registry in another window